North America Poultry Vaccines Market Forecast to 2031 – Regional Analysis – by Type (Broiler and Layer), Technology (Live Attenuated Vaccines, Inactivated Vaccines, and Recombinant Vaccines), Dosage Form (Liquid Vaccines, Freeze-Dried Vaccines, and Dust/Powdered Vaccines), Disease (Avian Influenza, Salmonellosis, Mareks Disease, Infectious Bronchitis (IB), Infectious Bursal Disease (IBD), Newcastle Disease, and Others), Route Of Administration (Drinking water (D/W), Intramuscular (I/M), Subcutaneous (S/C), and Others), and End User (Poultry Farms, Veterinary Hospitals, and Poultry Vaccination Centers and Clinics)
The North America poultry vaccines market was valued at US$ 702.04 million in 2023 and is expected to reach US$ 1,327.26 million by 2031; it is estimated to record a CAGR of 8.3% from 2023 to 2031.
Rising Prevalence of Poultry Diseases Fuels North America Poultry Vaccines Market
Poultry production results in producing different types of animal proteins through eggs and meat. With rising poultry production, there are high chances of susceptibility to several zoonotic diseases such as “Fowl disease” that might result in huge economic losses, particularly in developing countries. For example, chickens are more prone to bacterial, viral, parasitic, and fungal infections. These viral outbreaks can cause Newcastle Disease, Avian Influenza, Infectious Bursal Disease, and other diseases in other poultry animals.
The table below provides disease outbreaks of Avian Influenza among mammals across Canada in 2022.
Cases of Avian Influenza in Mammals | ||
Country | Poultry Diseases | Disease Outbreak (2022) |
Canada | 40 | |
Canada | H5N5 | 2 |
Source: World Organization for Animal Health 2023
Poultry diseases are a major cause of death of chicks and also lead to reduced livestock productivity of chickens. Farmers are facing huge economic losses worldwide as they spread zoonotic diseases, posing a serious health risk to mammals. For example, poultry coccidiosis is one of the most common diseases across the globe; it leads to huge losses associated with mortality, reduced body weight, and extra expenses related to preventive and therapeutic control. As per the DSM company website, farmers face an economic loss of US$ 3 billion annually owing to coccidiosis in chickens and avian species worldwide. Newcastle disease is also considered an economically expensive disease causing huge production losses to the farmers of developing countries that export poultry products.
Therefore, the rising prevalence of poultry diseases resulting in huge economic losses boosts the demand for poultry vaccinations, which drives the market.
North America Poultry Vaccines Market Overview
North America accounts major share for poultry vaccines market. Among the North America regional market, US accounts maximum share due to presence of top companies in the country and well-established centers providing vaccination services. Such aforementioned facts are one of the key factors that influence market growth in the region for the forecast period.
North America Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)
North America Poultry Vaccines Market Segmentation
The North America poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.
Based on type, the North America poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.
In terms of technology, the North America poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.
By dosage form, the North America poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.
Based on disease, the North America poultry vaccines market is segmented into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.
In terms of route of administration, the North America poultry vaccines market is categorized into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.
Based on end user, the North America poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.
By country, the North America poultry vaccines market is segmented into the US, Canada, and Mexico. The US dominated the North America poultry vaccines market share in 2023.
Starkey Laboratories Inc., Audina Hearing Instruments Inc, Sebotek Hearing Systems LLC, Earlens Corp, GN Store Nord AS, Cochlear Ltd, WS Audiology AS, Sonova Holding AG, Sonic Innovations Inc, and Amplifon Hearing Health Care Corp. are some of the leading companies operating in the North America poultry vaccines market.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
4. North America Poultry Vaccines Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Poultry Diseases
4.1.2 Growing Poultry Industry
4.2 Market Restraints
4.2.1 Vaccination Failure and Improper Handling
4.3 Market Opportunities
4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
4.4 Future Trends
4.4.1 Advancements in Vectored and Combination Vaccines
4.5 Impact of Drivers and Restraints:
5. North America Poultry Vaccines Market Analysis
5.1 Poultry Vaccines Market Revenue (US$ Million), 2023–2031
6. North America Poultry Vaccines Market Analysis – by Type
6.1 Overview
6.2 Broiler
6.2.1 Overview
6.2.2 Broiler: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Layer
6.3.1 Overview
6.3.2 Layer: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7. North America Poultry Vaccines Market Analysis – by Technology
7.1 Overview
7.2 Live Attenuated Vaccines
7.2.1 Overview
7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Inactivated Vaccines
7.3.1 Overview
7.3.2 Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Recombinant Vaccines
7.4.1 Overview
7.4.2 Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Poultry Vaccines Market Analysis – by Dosage Form
8.1 Overview
8.2 Liquid Vaccines
8.2.1 Overview
8.2.2 Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Freeze-Dried Vaccines
8.3.1 Overview
8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Dust/Powdered Vaccines
8.4.1 Overview
8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9. North America Poultry Vaccines Market Analysis – by Disease
9.1 Overview
9.2 Avian Influenza
9.2.1 Overview
9.2.2 Avian Influenza: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Salmonellosis
9.3.1 Overview
9.3.2 Salmonellosis: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Mareks Disease
9.4.1 Overview
9.4.2 Mareks Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.5 Infectious Bronchitis (IB)
9.5.1 Overview
9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.6 Infectious Bursal Disease (IBD)
9.6.1 Overview
9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.7 Newcastle Disease
9.7.1 Overview
9.7.2 Newcastle Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10. North America Poultry Vaccines Market Analysis – by Route of Administration
10.1 Overview
10.2 Drinking Water (D/W)
10.2.1 Overview
10.2.2 Drinking Water (D/W): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Intramuscular (I/M)
10.3.1 Overview
10.3.2 Intramuscular (I/M): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Subcutaneous (S/C)
10.4.1 Overview
10.4.2 Subcutaneous (S/C): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11. North America Poultry Vaccines Market Analysis – by End User
11.1 Overview
11.2 Poultry Farms
11.2.1 Overview
11.2.2 Poultry Farms: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.3 Veterinary Hospitals
11.3.1 Overview
11.3.2 Veterinary Hospitals: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.4 Poultry Vaccination Centers and Clinics
11.4.1 Overview
11.4.2 Poultry Vaccination Centers and Clinics: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12. North America Poultry Vaccines Market – Country Analysis
12.1 North America Market Overview
12.1.1 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
12.1.1.1 United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.1.1 Overview
12.1.1.1.2 United States: Poultry Vaccines Market Breakdown by Type
12.1.1.1.3 United States: Poultry Vaccines Market Breakdown by Technology
12.1.1.1.4 United States: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.1.5 United States: Poultry Vaccines Market Breakdown by Disease
12.1.1.1.6 United States: Poultry Vaccines Market Breakdown by Route Of Administration
12.1.1.1.7 United States: Poultry Vaccines Market Breakdown by End User
12.1.1.2 Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.2.1 Overview
12.1.1.2.2 Canada: Poultry Vaccines Market Breakdown by Type
12.1.1.2.3 Canada: Poultry Vaccines Market Breakdown by Technology
12.1.1.2.4 Canada: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.2.5 Canada: Poultry Vaccines Market Breakdown by Disease
12.1.1.2.6 Canada: Poultry Vaccines Market Breakdown by Route Of Administration
12.1.1.2.7 Canada: Poultry Vaccines Market Breakdown by End User
12.1.1.3 Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.1.3.1 Overview
12.1.1.3.2 Mexico: Poultry Vaccines Market Breakdown by Type
12.1.1.3.3 Mexico: Poultry Vaccines Market Breakdown by Technology
12.1.1.3.4 Mexico: Poultry Vaccines Market Breakdown by Dosage Form
12.1.1.3.5 Mexico: Poultry Vaccines Market Breakdown by Disease
12.1.1.3.6 Mexico: Poultry Vaccines Market Breakdown by Route Of Administration
12.1.1.3.7 Mexico: Poultry Vaccines Market Breakdown by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Poultry Vaccines Market
13.3 Organic Developments
13.3.1 Overview
13.1 Inorganic Developments
13.1.1 Overview
14. Company Profiles
14.1 Boehringer Ingelheim International GmbH
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Zoetis Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Phibro Animal Health Corp
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Dechra Pharmaceuticals PLC
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Elanco Animal Health Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck KGaA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Ceva
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Vaccinova AB
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
List of Tables
Table 1. North America Poultry Vaccines Market Segmentation
Table 2. United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 3. United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 4. United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 5. United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 6. United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 7. United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 8. Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 9. Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 10. Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 11. Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 12. Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 13. Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 14. Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 15. Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 16. Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 17. Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 18. Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route Of Administration
Table 19. Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms, Vaccine Adjuvants Market
List of Figures
Figure 1. North America Poultry Vaccines Market Segmentation, by Country
Figure 2. Poultry Vaccines Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Poultry Vaccines Market Revenue (US$ Million), 2023–2031
Figure 5. Poultry Vaccines Market Share (%) – by Type, 2023 and 2031
Figure 6. Broiler: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 7. Layer: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 8. Poultry Vaccines Market Share (%) – by Technology, 2023 and 2031
Figure 9. Live Attenuated Vaccines: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 10. Inactivated Vaccines: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 11. Recombinant Vaccines: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 12. Poultry Vaccines Market Share (%) – by Dosage Form, 2023 and 2031
Figure 13. Liquid Vaccines: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 14. Freeze-Dried Vaccines: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 15. Dust/Powdered Vaccines: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 16. Poultry Vaccines Market Share (%) – by Disease, 2023 and 2031
Figure 17. Avian Influenza: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 18. Salmonellosis: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 19. Mareks Disease: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 20. Infectious Bronchitis (IB): Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 21. Infectious Bursal Disease (IBD): Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 22. Newcastle Disease: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 24. Poultry Vaccines Market Share (%) – by Route of Administration, 2023 and 2031
Figure 25. Drinking Water (D/W): Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 26. Intramuscular (I/M): Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 27. Subcutaneous (S/C): Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 28. Others: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 29. Poultry Vaccines Market Share (%) – by End User, 2023 and 2031
Figure 30. Poultry Farms: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 31. Veterinary Hospitals: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 32. Poultry Vaccination Centers and Clinics: Poultry Vaccines Market– Revenue and Forecast to 2031 (US$ Million)
Figure 33. North America: Poultry Vaccines Market by Key Countries – Revenue (2023) US$ Million
Figure 34. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 35. United States: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 36. Canada: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 37. Mexico: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 38. Growth Strategies in the Poultry Vaccines Market
- Boehringer Ingelheim International GmbH.
- Zoetis Inc.
- Phibro Animal Health Corp.
- Dechra Pharmaceuticals PLC.
- Elanco Animal Health Inc.
- Merck KGaA.
- Ceva.
- Vaccinova AB.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America poultry vaccines market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America poultry vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America poultry vaccines market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.